Moreover, matrine restrains angiogenesis by reducing the expression of VEGF, EGF, VEGFR1, MMP-9, and MMP-2 in human non-small cell lung cancer (NSCLC) A549 cells and MDA-MB-231 cells21,30. Here, EGF is linked to non-small cell lung carcinoma.